Table 3B.
Description of the clinical and sleep profile of composite score decliners.
| N | Modality | Among composite score decliners | Among composite score non-decliners | ||||
|---|---|---|---|---|---|---|---|
| Time in bed <8.5 h | Time in bed >8.5 h | P-Chi2 | Time in bed < 8.5 h | Time in bed >8.5 h | P-Chi2 | ||
| N = 24 | N = 25 | N = 264 | N = 160 | ||||
| Age | (Years) | 75.0 [70–84] | 74.0 [70–87] | 0.53** | 74.0 [70–88] | 74.0 [70–88] | 0.28** |
| Sex | Women | 17 (70.8%) | 16 (64.0%) | 0.61 | 182 (68.9%) | 106 (66.3%) | 0.57 |
| Men | 7 (29.2%) | 9 (36.0%) | 82 (31.1%) | 54 (33.8%) | |||
| BMI | Normal | 10 (41.7%) | 11 (44.0%) | 0.87 | 124 (47.1%) | 65 (40.9%) | 0.21 |
| Overweight or obese | 14 (58.3%) | 14 (56.0%) | 139 (52.9%) | 94 (59.1%) | |||
| CV and metabolic diseases | Absence | 8 (33.3%) | 5 (20.0%) | 0.29 | 96 (36.4%) | 67 (41.9%) | 0.26 |
| Presence | 16 (66.7%) | 20 (80.0%) | 168 (64.6%) | 93 (58.1%) | |||
| Hypnotics intake | No | 20 (83.3%) | 17 (68.0%) | 0.21 | 221 (83.7%) | 123 (76.9%) | 0.08 |
| Yes | 4 (16.7%) | 8 (32.0%) | 43 (16.3%) | 37 (23.1%) | |||
| Fatigue scale | T1: [0–4] | 6 (28.6%) | 3 (13.6%) | 0.28* | 71 (28.1%) | 48 (31.6%) | 0.45 |
| T2+T3: [5–14] | 15 (71.4%) | 19 (86.4%) | 182 (71.9%) | 104 (68.4%) | |||
| Depression (BDI scale) | Non-depressed: <11 | 12 (66.7%) | 17 (73.9%) | 0.61 | 181 (73.0%) | 105 (70.0%) | 0.52 |
| Depressed: >11 | 6 (33.3%) | 6 (26.1%) | 67 (27.0%) | 45 (30.0%) | |||
| Night-time sleep | (Hour) | 7 [3.5–8.25] | 8 [5–10] | 0.02** | 6.5 [3.5–8] | 8 [4–10] | <0.0001** |
| Day-time sleep | (Hour) | 20 [0–60] | 20.0 [0–120] | 0.84** | 15.0 [0–180] | 20 [0–140] | 0.13** |
| Naps | No | 9 (40.9%) | 8 (33.3%) | 0.59 | 119 (48.0%) | 63 (40.9%) | 0.17 |
| Yes | 13 (59.1%) | 16 (66.7%) | 129 (52.0%) | 91 (59.1%) | |||
| Total sleep | Day+night (hour) | 7.1 [4.1–8.5] | 8.3 [5.0–10.5] | 0.009** | 7.0 [4.0–11.0] | 8.3 [4.0–11.0] | <0.0001** |
| Sleep efficiency | (%) | 87.5 [50–100] | 80 [52.6–100] | 0.21** | 87.5 [43.8–100] | 88.9 [33.3–100] | 0.04** |
| WASO | (Hour) | 1 [0–4] | 2 [0–4.5] | 0.02** | 1 [0–4.5] | 1 [0–8] | <0.0001** |
| EDS | <10 | 18 (78.3%) | 17 (80.9%) | 0.99* | 175 (78.1%) | 117 (80.7%) | 0.55 |
| >10 | 5 (21.7%) | 4 (19.1%) | 49 (21.9%) | 28 (19.3%) | |||
| Insomnia severity | <7 | 17 (70.8%) | 13 (52.0%) | 0.18 | 130 (49.8%) | 88 (56.1%) | 0.22 |
| >7 | 7 (29.2%) | 12 (48.0%) | 131 (50.2%) | 69 (44.0%) | |||
| RLS | 4 signs | 4 (17.4%) | 3 (12.0%) | 0.70* | 47 (17.9%) | 21 (13.3%) | 0.21 |
| Less than 4 signs | 19 (82.6%) | 22 (88.0%) | 215 (82.1%) | 137 (86.7%) | |||
| RBD | No | 13 (81.2%) | 19 (79.2%) | 0.99* | 162 (85.3%) | 122 (91.7%) | 0.08 |
| Yes | 3 (18.8%) | 5 (20.8%) | 28 (14.7%) | 11 (8.3%) | |||
| Risk of apnea | No | 9 (50.0%) | 9 (42.9%) | 0.66 | 105 (58.7%) | 721(66.4%) | 0.2 |
| Yes | 9 (50.0%) | 12 (57.1%) | 74 (41.3%) | 36 (33.6%) | |||
*
Fisher exact test.
**
Wilcoxon rank test.
The bold values mean that the result is significant with a p-value < 0.05.